Chetasi Talati
- Hematology top 2%
- Acute Myeloid Leukemia Research 58
- Chronic Myeloid Leukemia Treatments 28
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 31
- Chronic Lymphocytic Leukemia Research 10
-
- Cancer Genomics and Diagnostics 5
- Oncology top 10%
- Hepatology top 10%
-
- Acute Lymphoblastic Leukemia research 7
-
- Eosinophilic Disorders and Syndromes 6
-
- Histone Deacetylase Inhibitors Research 6
- Co-authors
- Dae Won KimRichard D. KimKendra SweetJeffrey E. LancetDavid A. SallmanJavier Pinilla‐IbarzEric PadronRami S. Komrokji
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Chetasi Talati
72 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 70
- Hematology 592
- Genetics 326
- Cancer Research 157
- Oncology 247
- Hepatology 68
Countries citing papers authored by Chetasi Talati
This map shows the geographic impact of Chetasi Talati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chetasi Talati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chetasi Talati more than expected).
Fields of papers citing papers by Chetasi Talati
This network shows the impact of papers produced by Chetasi Talati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chetasi Talati. The network helps show where Chetasi Talati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chetasi Talati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 23 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 35 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 0 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 2 | |
| 16 | 2017 | 255 | |
| 17 | 2017 | 94 | |
| 18 | 2016 | 15 | |
| 19 | 2015 | 25 | |
| 20 | 2014 | 9 |
About Chetasi Talati
Chetasi Talati is a scholar working on Hematology, Genetics and Oncology, having authored 78 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (58 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (31 papers), Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (7 papers), Eosinophilic Disorders and Syndromes (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Hematology (592 citations), Genetics (326 citations) and Cancer Research (157 citations). Chetasi Talati has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Dae Won Kim, Richard D. Kim, Kendra Sweet, Jeffrey E. Lancet, David A. Sallman, Javier Pinilla‐Ibarz, Eric Padron, Rami S. Komrokji, Alan F. List and Andrew Kuykendall. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, Blood Advances and Current Opinion in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.